Ken Iwai

Title: Ken Iwai: Innovator in Antitumor Drug Formulations

Introduction

Ken Iwai is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oily compositions for antitumor drugs. With a total of 2 patents to his name, Iwai's work is recognized for its innovative approach to drug delivery systems.

Latest Patents

Iwai's latest patents include two key formulations. The first patent is for an "Oily composition of aclarubicin or hydrochloride thereof," which comprises aclarubicin or aclarubicin hydrochloride, at least one fatty acid selected from saturated medium chain fatty acids, unsaturated medium chain fatty acids, and unsaturated long chain fatty acids, along with at least one fat or oil selected from iodized oils and vegetable oils. The second patent focuses on "Oily compositions of antitumor drugs," which includes at least one sparingly oil-soluble or water-soluble antitumor drug, at least one fat or oil, and at least one solubilizing adjuvant in an oily vehicle selected from a group consisting of crown ether, lecithin, polyethylene glycol, propylene glycol, vitamin E, polyoxyethylene alkylether, and sucrose esters of fatty acids.

Career Highlights

Ken Iwai is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that enhance the efficacy and delivery of antitumor medications.

Collaborations

Iwai has collaborated with notable colleagues such as Hiroitsu Kawata and Shunji Hasumi, further enriching his research and development efforts in the pharmaceutical industry.

Conclusion

Ken Iwai's contributions to the field of antitumor drug formulations highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing pharmaceutical technology, making a significant impact in the industry.